arrow
R

Robert W. Siegel

Eli Lilly
H指数:30
被引数:5,318

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Effects of fenofibrate on angiopoietin-like 3/4/8 proteins and apolipoprotein A5

杨, Y.; Smith, S.; 陈, Y.Q.; 李, H.; Zhen, E.Y.; Sloan, J.H.; Siegel, R.W.; 钱Y.; 温, Y.; Jung, H.; 等. 非诺贝特对 angiopoietin-like 3/4/8 蛋白和载脂蛋白 A5 的影响. 脂质研究杂志, 2026, 101050. [Google Scholar] [CrossRef]

2026-06-011
OA
Proceedings of the 2024 FDA-CRCG Workshop: Scientific and Regulatory Considerations for Assessment of Immunogenicity Risk for Generic Peptide and Oligonucleotide Drug Products

2024年FDA-CRCG研讨会论文集:评估仿制肽类和寡核苷酸药物产品免疫原性风险的科学与监管考量

2026-02-120
PRE
Carboxyl- terminal sequences in APOA5 are important for suppressing ANGPTL3/8 activity

APOA5中的羧基末端序列对于抑制ANGPTL3/8活性很重要

2024-04-163
PRE
Development of a long-acting relaxin analogue, LY3540378, for treatment of chronic heart failure
2023-03-0814
OA
LY-CoV1404 (bebtelovimab) potently neutralizes SARS-CoV-2 variants
2022-05-01281
OAAI